Abstract
T. L.is a 29-year-old female who presents to her primary care physician in August complaining of a stuffy, itchy nose; sneezing; intermittent headache; and daytime somnolence for the past several months. She notes that since moving to Washington, DC 3 years ago, these same symptoms seem to bother her every spring and summer. She has tried over-the-counter pseudoephedrine with mild relief of congestion. She feels her symptoms are interfering with her ability to exercise outdoors and her performance at work. Her past medical history is significant for eczema as a child. Her father has had “hay fever” for years. She lives alone in an apartment and has no pets. Physical exam is remarkable for a bilaterally indurated, erythematous nasal mucosa, a clear, watery anterior and posterior nasal discharge, an erythematous oropharynx, and bilateral tenderness over the frontal sinuses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bousquet J, van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147–S334.
Kramer MF, Ostertag P, Pfrogner E, Rasp G. Nasal interleukin-5, immunoglobulin E, eosinophillic cationic protein, and soluble intercellular adhesion molecule-1 in chronic si nusitis, allergic rhinitis, and nasal polyposis. Laryngoscope 2000;1101056–1062.
Dey AN, Schiller JS, Tai DA. Summary health statistics for U.S. children: National Health Interview Survey, 2003. National Center for Health Statistics. Vital Health Stat 2005;223:1–78.
Lethbridge-Cejku M, Schiller JS, Bernadel L. Summary health statistics for U.S. adults: National Health Interview Survey, 2002. National Center for Health Statistics. Vital Health Stat 2004; 10: 27–28.
Conner SJ. Evaluation and treatment of the patient with allergic rhinitis. J Fam Practice 2002;51:883–884, 887-890.
Baraniuk JN. Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 1997;99:763–772.
Kakumanu S, Glass C, Craig T. Poor sleep and daytime somnolence in allergic rhinitis: significance of nasal congestion. Am J Resp Med 2002; 1:195–200.
Diaz-Sanchez D, Tsien A, Casillas A, Dotson AR, Sackson A. Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. J Allergy Clin Immunol 1996;98:114–123.
Takenaka H, Zhang K, Diaz-Sanchez D, Tsein A, Sackson A. Enhanced human IgE production results from exposure to the aromatic hydrocarbons from diesel exhaust: direct effects on B cell IgE production. J Allergy Clin Immunol 1995;95:103–115.
Ng MLS, Warlow RS, Chrishanthan N, Ellis C, Walls RS. Preliminary criteria for the definition of allergic rhinitis: a systematic evaluation of clinical parameters in a disease cohort (I and II). Clin Exper Allergy 2000;30:1314–1331, 1417-1422.
Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med 2004; 140: 278–289.
Szeinbach SL, Barnes JH, Sullivan TJ, Williams PB. Precision and accuracy of commercial laboratories’ ability to classify positive and/or negative allergen-specific IgE results. Ann Allergy Asthma Immunol 2001;86:373–381.
Sheikh A, Hurwitz B. House dust mite avoidance measures for perennial allergic rhinitis: a systematic review of efficacy. British J Gen Practice 2003;53:318–322.
McDonald LG, Tovey E. The role of water temperature and laundry procedures in reducing house dust mite populations and allergen content of bedding. J Allergy Clin Immunol 1992;90:599–608.
Ehnert B, Lau-Schadendorf S, Weber A, Buettner P, Schou C, Wahn U. Reducing domestic exposure to dust mite allergen reduces bronchial hyperreactivity in sensitive children with asthma. J Allergy Clin Immunol 1992;90:135–138.
Brunekreef B. On carpets, construction and covers. Clin Exp Allergy 1999;29:433–435.
Roberts JW, Clifford WS, Glass G, Hummer PG. Reducing dust, lead, dust mites, bacteria, and fungi in carpets by vacuuming. Arch Environ Contam Toxicol 1999;36:477–484.
Warner J, Frederick JM, Bryant TN, et al. Mechanical ventilation and high efficiency vacuum cleaning: a combined strategy of mite and mite allergen reduction in the control of mite sensitive asthma. J Allergy Clin Immunol 2000;105:75–82.
de-Blay F, Chapman MD, Platts-Mills TA. Airborne cat allergen (Fel d I). Environmental control with the cat in situ. Am Rev Respir Dis 1991;143:1334–1339.
Gergen PJ, Mortimer KM, Eggleston PA, et al. Results of the National Cooperative Inner-City Asthma Study (NCICAS) environmental intervention to reduce cockroach allergen exposure in inner-city homes. J Allergy Clin Immunol 1999;103:501–506.
Corren, J. Allergic rhinitis: treating the adult. J Allergy Clin Immunol 2000; 105: S610–S615.
Borish L. Allergic rhinitis: systemic inflammation and implications for management. J Allergy Clin Immunol 2003;112:1021–1031.
Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 2000;105:917–922.
Hadley JA. Cost-effective pharmacotherapy for inhalant allergic rhinitis. Otolaryngol Clin North Am 2003;36:825–836.
Nielsen LP, Dahl R. Comparison of intranasal corticosteroids and antihistamines in allergic rhinitis: a review of randomized, controlled trials. Am J Resp Med 2003;2: 55–65.
Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998;317:1624–1629.
Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med 1999;341:468–475.
Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Inter Med 2004; 140:278–289.
Guerra S, Sherrill D, Martinez F, Barbee R. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002;109:419–425.
Fuhlbrigge AL, Adams RJ. The effect of treatment of allergic rhinitis on asthma morbidity, including emergency department visits. Curr Opin Allergy Clin Immunol 2003;3: 29–32.
Smith H, White P, Annila I, et al. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 2004;114:512–516.
Novembre E, Galli E, Landi E, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004; 114:851–857.
Finn A, Gross G, Van Bavel J, et al. Omalizumab improves asthma-related quality of life in patients with severe allergic asthma. J Allergy Clin Immunol 2003;111:278–284.
Rolinck-Werninghaus C, Hamelmann E, Keil T, et al. The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children Allergy 2004;59:973–979.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Sobota, H.B., Emdadi, T., Mintz, M.L. (2006). Allergic Rhinitis. In: Mintz, M.L. (eds) Disorders of the Respiratory Tract. Current Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-59745-041-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-59745-041-6_4
Publisher Name: Humana Press
Print ISBN: 978-1-58829-556-9
Online ISBN: 978-1-59745-041-6
eBook Packages: MedicineMedicine (R0)